Reports on the top holdings of various healthcare and biotech ETFs, listing major pharmaceutical companies like Eli Lilly, Amgen, and Johnson & Johnson.

1 report, 1 independent Updated Sep 9

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Eli Lilly and Company Amgen Johnson & Johnson

Keep exploring

Part of

Several healthcare ETFs hold major pharmaceutical companies like Eli Lilly, J&J, and Novo Nordisk as top 3 positions, leading to competition for investor capital. All 1 developments

The entities involved

Eli Lilly and Company
American pharmaceutical company
- Eli Lilly and Company is expanding into psychedelic and neuroscience pipelines, adding late-stage psychedelic assets through acquisition.16:23
- Eli Lilly and Company now owns the drugmaker AtaiBeckley.16:23
Amgen
American multinational biopharmaceutical company
- A Harvard instructor attended a Life Sciences Summit while Michaela Kerrissey is an associate professor and Stanley Shaw leads Amgen.13:45
- Amgen and Google stock movements offset each other on October 29, 2026.Thu 17:55
Johnson & Johnson
company in Pomezia, Italy

Nothing else this week.

Coverage

Newest first; wire copies grouped

Sep 9fool.com